AbbVie Inc at Bank of America Merrill Lynch Health Care Conference Transcript
My name is Jason Gerberry. I'm the U.S. pharma analyst here at Bank of America. I'm pleased to be introducing AbbVie. I'm joined by Mike Severino, Vice Chairman and President; and Rob Michael, Chief Financial Officer. So gentlemen, thank you so much for joining us at our conference.
Pleasure to be here.
Thanks for having us.
Questions & Answers
Yes. So in terms of the questions, it's probably not a surprise to focus on immunology and your hematology franchises and either your recent launches and your pipeline. So maybe we can start on the immunology side and your recent launch of SKYRIZI. I think as we think about this story, what probably caught a lot of the investors'
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
